New research shows that fecal transplants may boost the effectiveness of cancer immunotherapy drugs called PD-1 inhibitors.

DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) has entered into a Material Transfer Agreement (MTA) with MD ...

Metastatic prostate cancer patients in the Capital Region now have a new treatment option at Ochsner MD Anderson Cancer ...

MD Anderson isn’t the only cancer center that health insurers leave out of ACA plans. A 2018 survey found that among 29 high-level cancer centers in 21 states, 93% were out of network for some ...

Aprea Therapeutics (APRE) has entered into a Material Transfer Agreement with MD Anderson Cancer Center. Under the agreement, Aprea will supply ...

Beyond documentation, healthcare technology company Baxter announced a wearable badge for nurses on Tuesday called Voalte ...

Aprea Therapeutics Inc. has entered into a material transfer agreement with MD Anderson Cancer Center that will support investigation of APR-1051 as a potential treatment for head and neck squamous ...

MD Anderson says the collaborative, set to begin in 2026, will combine the two institutions’ patient populations to “increase pediatric cancer clinical trials.” ...

MD Anderson Cancer Center at Cooper opened a state-of-the-art radiation oncology suite at the Cooper University Health Care ...

The University of Texas MD Anderson Cancer Center today announced a $9 million gift from the F. W. Bert and Mae Dean Wheeler Foundation to establish the F. W. Bert and Mae Dean Wheeler Nurse ...